Literature DB >> 14730708

Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera.

Tania Borda1, Ricardo Gomez, Maria I Berría, Leonor Sterin-Borda.   

Abstract

We demonstrated the presence of circulating antibodies from schizophrenic patients able to interact with cultured astrocytes activating muscarinic acetylcholine receptors (mAChRs). Sera and purified IgG from 15 paranoid schizophrenic and 15 age-matched normal subjects were studied by indirect immunofluorescence (IFI), flow cytometry, dot blot, enzyme immunoassay (ELISA), and radioligand competition assays. Astrocyte membranes and/or a synthetic peptide, with identical amino acid sequence of human M(1) and M(2) mAChR, were used as antigens. By IFI and flow cytometry procedures, we proved that serum purified IgG fraction from schizophrenic patients, reacted to astrocyte cell surface. The same antibodies were able to inhibit the binding of the specific mAChR radioligand (3)H-QNB. Using synthetic peptide for dot blot and ELISA, we demonstrated that these antibodies reacted against the second extracellular loop of human cerebral M(1) and M(2) mAChR. Also, the corresponding affinity-purified antipeptide antibody displayed an agonistic-like activity associated to specific M(1) and M(2) mAChR activation, increasing inositol phosphates accumulation and decreasing cyclic AMP production, respectively. This article gives support to the participation of an autoimmune process in schizophrenia disease. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730708     DOI: 10.1002/glia.10312

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  8 in total

1.  Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders.

Authors:  Demian Obregon; Ellisa Carla Parker-Athill; Jun Tan; Tanya Murphy
Journal:  Neuropsychiatry (London)       Date:  2012-08

2.  Schizophrenia: a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes.

Authors:  C J Carter
Journal:  J Pathog       Date:  2011-05-26

3.  Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies.

Authors:  Wai Hong Wilson Tang; Sathyamangla V Naga Prasad
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

4.  A case of GABAR antibodies in schizophrenia.

Authors:  Ida S Haussleiter; Klaus-Peter Wandinger; Georg Juckel
Journal:  BMC Psychiatry       Date:  2017-01-10       Impact factor: 3.630

Review 5.  A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis.

Authors:  Souhel Najjar; Johann Steiner; Amanda Najjar; Karl Bechter
Journal:  J Neuroinflammation       Date:  2018-02-13       Impact factor: 8.322

6.  Brain antibodies in the cortex and blood of people with schizophrenia and controls.

Authors:  L J Glass; D Sinclair; D Boerrigter; K Naude; S J Fung; D Brown; V S Catts; P Tooney; M O'Donnell; R Lenroot; C Galletly; D Liu; T W Weickert; C Shannon Weickert
Journal:  Transl Psychiatry       Date:  2017-08-08       Impact factor: 6.222

7.  Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives.

Authors:  Evgeny A Ermakov; Mark M Melamud; Valentina N Buneva; Svetlana A Ivanova
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

Review 8.  Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders.

Authors:  Pilar Martinez-Martinez; Peter C Molenaar; Mario Losen; Jo Stevens; Marc H De Baets; Andrei Szoke; Jerome Honnorat; Ryad Tamouza; Marion Leboyer; Jim Van Os; Bart P F Rutten
Journal:  Front Genet       Date:  2013-09-20       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.